Skip to main content

Table 1 Clinical and laboratory characteristics

From: Relationship among coronary plaque compliance, coronary risk factors and tissue characteristics evaluated by integrated backscatter intravascular ultrasound

  Arc of calc ≤10° 10° < Arc of calc ≤60° p value
  (n = 36) (n = 22)  
Men, % 31 (86) 15 (68) 0.18
Age, y 65 ± 10 72 ± 9 0.007
Clinical history, n (%)
Myocardial infarction 10 (28) 7 (32) 0.74
Previous coronary bypass graft 1 (3) 1 (5) >0.99
Hypertension 25 (69) 15 (68) 0.92
Dyslipidemia 23 (64) 17 (77) 0.38
Current smoker 6 (17) 3 (14) >0.99
Diabetes mellitus type 2 19 (53) 10 (45) 0.59
Target plaque location, n (%)
LAD 22 (61) 16 (72) 0.37
LCX 14 (39) 6 (28)  
Medication, n (%)
Anti-platelet medicine 36 (100) 22 (100) >0.99
Statin 14 (39) 15 (68) 0.030
Calcium channel blockers 16 (44) 8 (36) 0.54
Beta-blockers 6 (17) 4 (18) >0.99
Insulin 4 (11) 5 (23) 0.42
ARBs or ACEIs 20 (56) 13 (59) 0.79
Laboratory parameter
Total cholesterol (mg/dl) 205 ± 37 173 ± 27 <0.001
Triglycerides (mg/dl) 160 ± 96 145 ± 58 0.45
HDL cholesterol (mg/dl) 50 ± 9 45 ± 11 0.12
LDL cholesterol (mg/dl) 120 ± 38 98 ± 30 0.003
Hemoglobin A1c (%) 6.6 ± 0.9 6.6 ± 0.8 0.58
C-reactive protein (mg/dl) 0.75 ± 0.51 0.15 ± 0.16 0.16
Blood pressure during catheterization
Systolic pressure (mmHg) 147 ± 25 149 ± 29 0.79
Diastolic pressure (mmHg) 74 ± 13 74 ± 13 0.37
  1. Values are mean ± SD. Calc: calcification, LAD: left anterior descending, LCX: left circumflex, ARBs: angiotensin II receptor blockers, ACEIs: angiotensin-converting enzyme inhibitors.
  2. NGSP: National Glycohemoglobin Standardization Program.